JP2025515165A5 - - Google Patents
Info
- Publication number
- JP2025515165A5 JP2025515165A5 JP2024565175A JP2024565175A JP2025515165A5 JP 2025515165 A5 JP2025515165 A5 JP 2025515165A5 JP 2024565175 A JP2024565175 A JP 2024565175A JP 2024565175 A JP2024565175 A JP 2024565175A JP 2025515165 A5 JP2025515165 A5 JP 2025515165A5
- Authority
- JP
- Japan
- Prior art keywords
- factor
- polypeptide
- modified
- nucleic acid
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263339230P | 2022-05-06 | 2022-05-06 | |
| US63/339,230 | 2022-05-06 | ||
| PCT/US2023/066676 WO2023215879A1 (en) | 2022-05-06 | 2023-05-05 | Modified factor xa polypeptides and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025515165A JP2025515165A (ja) | 2025-05-13 |
| JP2025515165A5 true JP2025515165A5 (https=) | 2026-04-28 |
Family
ID=87474126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024565175A Pending JP2025515165A (ja) | 2022-05-06 | 2023-05-05 | 改変されたＸａ因子ポリペプチドおよび使用方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250302927A1 (https=) |
| EP (1) | EP4519431A1 (https=) |
| JP (1) | JP2025515165A (https=) |
| WO (1) | WO2023215879A1 (https=) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019246094A1 (en) * | 2018-06-19 | 2019-12-26 | Portola Pharmaceuticals, Inc. | Antidotes to factor xa inhibitors |
-
2023
- 2023-05-05 EP EP23745709.8A patent/EP4519431A1/en active Pending
- 2023-05-05 WO PCT/US2023/066676 patent/WO2023215879A1/en not_active Ceased
- 2023-05-05 US US18/863,242 patent/US20250302927A1/en active Pending
- 2023-05-05 JP JP2024565175A patent/JP2025515165A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3176604B2 (ja) | Ｘａ因子インヒビターおよびそれを含有する医薬組成物 | |
| JP2011530599A5 (https=) | ||
| JP2010516290A5 (https=) | ||
| JPWO2019156137A5 (https=) | ||
| JP2004203890A (ja) | マクロファージ炎症蛋白変種 | |
| JP2005520834A5 (https=) | ||
| KR20060023968A (ko) | 중증 급성 호흡기 증후군(ｓａｒｓ)의 치료를 위한 조성물및 방법 | |
| JP2021532791A5 (https=) | ||
| US20240342211A1 (en) | Short-term activated dc1s and methods for their production and use | |
| JP2022500353A (ja) | Ｉｇｆ−１−暗号化ｄｎａ作製物及びｈｇｆ−暗号化ｄｎａ作製物を用いた神経病症治療 | |
| CN104168910B (zh) | 肽及其用途 | |
| JP2025515165A5 (https=) | ||
| JP2015523861A (ja) | 制御された遺伝子発現方法 | |
| JP7066409B2 (ja) | 癌または転移性疾患の治療または予防における環状アセチルコリンエステラーゼｃ末端ペプチド | |
| KR20230027279A (ko) | 화학요법-유발성 독성을 완화하기 위한 내피 세포 | |
| JPH04502904A (ja) | 両親媒性ペプチドの投与方法およびその組成物 | |
| JPWO2021229076A5 (https=) | ||
| CN113508126A (zh) | 新型肽及其用途 | |
| WO2000074688A1 (en) | Methods for preventing formation of inhibitory antibodies in the setting of gene therapy | |
| JPWO2020025642A5 (https=) | ||
| US20250066438A1 (en) | Methods and compositions for preventing or treating cancer | |
| JPWO2022215032A5 (https=) | ||
| US9327013B2 (en) | Activity enhancer for anticancer agent | |
| JPWO2023102463A5 (https=) | ||
| US11414468B2 (en) | Factor B and C2 protein point mutants, a method for enhancing the activity of anti-cancer antibodies, the pharmaceutical composition and the use of mutants |